Daniel Eiger

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial

Jens Huober, Carlos H. Barrios, Naoki Niikura et al. · Journal of Clinical Oncology · 2022 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

Maria Alice Franzoi, Daniel Eiger, Lieveke Ameye et al. · JNCI Journal of the National Cancer Institute · 2020 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center

Bernard Lobato Prado, Diogo Bugano Diniz Gomes, Pedro Luiz Serrano Usón Júnior et al. · BMC Palliative Care · 2018 · 45 citations · Full text

Medicine, Oncology, End-of-life Care +15

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors

Maria Alice Franzoi, Caroline Vandeputte, Daniel Eiger et al. · Breast Cancer Research and Treatment · 2020 · 40 citations · Full text

Medicine, Oncology, Radiology +15

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

Daniel Eiger, Noam Pondé, Dominique Agbor‐Tarh et al. · British Journal of Cancer · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17